Literature DB >> 10725695

Cutting edge: recombinase-activating gene expression and V(D)J recombination in CD4+CD3low mature T lymphocytes.

E Lantelme1, B Palermo, L Granziero, S Mantovani, R Campanelli, V Monafo, A Lanzavecchia, C Giachino.   

Abstract

The recombinase-activating genes, RAG-1 and RAG-2, can be expressed by a subset of B cells within germinal centers, where they mediate secondary V(D)J rearrangements. This receptor revision mechanism could serve either receptor diversification or tolerance-induced functions. Alternatively, it might rescue those cells the receptors of which have been damaged by somatic mutation. Less is known about the occurrence of similar mechanisms in T cells. Here we show that mature T cells with defective TCR surface expression can express RAG genes and are capable of initiating secondary V(D)J rearrangements. The possibility that a cell rescue mechanism based on the generation of a novel Ag receptor might be active in peripheral T cells is envisaged.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725695     DOI: 10.4049/jimmunol.164.7.3455

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Multiple T-cell clones specific for the same foreign pMHC ligand can be generated from a single, ancestral TCR-VDJbeta precursor.

Authors:  Janet L Maryanski; Anne Aublin; Valérie Attuil-Audenis; Abdelbasset Hamrouni
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  TCR revision generates functional CD4+ T cells.

Authors:  J Scott Hale; Maramawit Wubeshet; Pamela J Fink
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

Review 3.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

4.  Modulation of TCRβ surface expression during TCR revision.

Authors:  Kalynn B Simmons; Maramawit Wubeshet; Kristina T Ames; Catherine J McMahan; J Scott Hale; Pamela J Fink
Journal:  Cell Immunol       Date:  2011-11-15       Impact factor: 4.868

5.  RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.

Authors:  Pau Serra; Abdelaziz Amrani; Bingye Han; Jun Yamanouchi; Shari J Thiessen; Pere Santamaria
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

Review 6.  T-cell receptor revision: friend or foe?

Authors:  J Scott Hale; Pamela J Fink
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

7.  Human CD4+CD3- innate-like T cells provide a source of TNF and lymphotoxin-αβ and are elevated in rheumatoid arthritis.

Authors:  Vasileios Bekiaris; John R Šedy; Maura Rossetti; Roberto Spreafico; Shilpi Sharma; Antje Rhode-Kurnow; Brian C Ware; Nini Huang; Matthew G Macauley; Paula S Norris; Salvatore Albani; Carl F Ware
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

8.  T cells from epicutaneously immunized mice are prone to T cell receptor revision.

Authors:  Margaret S Bynoe; Christophe Viret; Richard A Flavell; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

9.  Receptor revision in CD4 T cells is influenced by follicular helper T cell formation and germinal-center interactions.

Authors:  Lauren E Higdon; Katherine A Deets; Travis J Friesen; Kai-Yin Sze; Pamela J Fink
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

10.  The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.

Authors:  Valentina Turinetto; Paola Porcedda; Luca Orlando; Mario De Marchi; Antonio Amoroso; Claudia Giachino
Journal:  BMC Cancer       Date:  2009-08-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.